Grisanti Capital Management’s AbbVie ABBV Stock Holding History

Grisanti Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$11.7M	Buy	153,099 +25,793	+20%	+$2.2M	7.17%	2
2019 Q4	$11.3M	Sell	127,306 -7,751	-6%	-$643K	5.44%	3
2019 Q3	$10.2M	Buy	+135,057	New	+$9.26M	5.59%	4
2016 Q2	–	Sell	-153,785	Closed	-$8.78M	–	51
2016 Q1	$8.78M	Sell	153,785 -237,230	-61%	-$13.2M	4.13%	9
2015 Q4	$23.2M	Sell	391,015 -13,535	-3%	-$780K	10.3%	1
2015 Q3	$22M	Buy	404,550 +42,280	+12%	+$2.75M	8.74%	1
2015 Q2	$24.3M	Sell	362,270 -44,115	-11%	-$2.88M	9.1%	1
2015 Q1	$23.8M	Buy	406,385 +192,950	+90%	+$11.7M	8.9%	1
2014 Q4	$14M	Buy	213,435 +84,340	+65%	+$5.32M	5.25%	4
2014 Q3	$7.46M	Buy	+129,095	New	+$7.17M	3.01%	16

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Grisanti Capital Management's ABBV Position: Q1 2020 in Review

Grisanti Capital Management increased its AbbVie (ABBV) stake by 20% in Q1 2020, buying an estimated $2.2M and bringing the position to 153,099 shares worth $11.7M. The position accounts for 7.17% of the portfolio, ranked #2.

Grisanti Capital Management first reported a position in ABBV in Q3 2014 and has held it in 10 quarters since. The position peaked at $24.3M in Q2 2015. 2,225 funds tracked by Wall St. Rank hold ABBV as of Q1 2020.

Grisanti Capital Management held 153,099 shares of AbbVie worth $11.7M as of Q1 2020.
Grisanti Capital Management bought 25,793 AbbVie shares in Q1 2020, an estimated $2.2M.
AbbVie made up 7.17% of Grisanti Capital Management's portfolio in Q1 2020, its #2 holding.
Grisanti Capital Management first reported a position in AbbVie in Q3 2014 and has held it in 10 quarters since.
Grisanti Capital Management's AbbVie position peaked at $24.3M in Q2 2015.
2,225 funds tracked by Wall St. Rank held AbbVie as of Q1 2020.

Based on Grisanti Capital Management's 13F filing for Q1 2020, filed 6 May 2020.